HCV-positive allograft use in heart transplantation is associated with increased access to overdose donors and reduced waitlist mortality without compromising outcomes | HCV Guidance

HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C

HCV-positive allograft use in heart transplantation is associated with increased access to overdose donors and reduced waitlist mortality without compromising outcomes

Altshuler PJ, Helmers MR, Schiazza AR, et al. HCV-positive allograft use in heart transplantation is associated with increased access to overdose donors and reduced waitlist mortality without compromising outcomes. J Card Fail [Internet]. 2022;28(1):32-41. https://doi.org/10.1016/j.cardfail.2021.07.007

Publication Type:

Journal Article

Authors:

Altshuler, PJ; Helmers, MR; Schiazza, AR; et, al

Source:

J Card Fail, Volume 28, Issue 1, p.32-41 (2022)

URL:

https://doi.org/10.1016/j.cardfail.2021.07.007

Keywords:

drug overdose, heart transplantation, hepatitis C virus, waitlist mortality

Cited On:

Treatment of HCV-Uninfected Transplant Recipients Receiving Organs From HCV-Viremic Donors

External Third-party Web Link:

https://pubmed.ncbi.nlm.nih.gov/34314824/

Export Citation:

RIS Format

Top